AB Science webcast – Microtubule Destabilizer Agents (MDA) platform
16/03/2023 – Presentation of the AB Science Microtubule Destabilizer Agents platform webcast
16/03/2023 – Presentation of the AB Science Microtubule Destabilizer Agents platform webcast
15/03/2023 – AB Science will host a live webcast on Thursday March 16, 2023, from 6pm to 7pm CET, to present the ongoing phase 1/2 with AB8939 and its synthetic microtubule destabilizer agents (MDA) platform
13/03/2023 – AB Science today announces a case report from the initial stage of its Phase I/II study (AB18001) evaluating AB8939, a microtubule destabilizer, in patients with refractory and relapsed acute myeloid leukemia (AML)